Stockreport

Allergan Announces FDA Acceptance of New Drug Application for Ubrogepant for the Acute Treatment of Migraine

ALLERGAN INC  (AGN) 
Last allergan inc earnings: 2/10 07:00 am Check Earnings Report
US:NYSE Investor Relations: allergan.com/investors